Weight loss in patients with type 2 diabetes receiving once-weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: A post-hoc analysis of the AWARD-4 study across baseline body mass index subgroups Fuechtenbusch, Martin Aberle, Jens Heitmann, Elke Nicolay, Claudia Jung, Heike 2019 - Forschungsinformationssystem des UKE